Microglial Activation in Parkinson's Disease

Microglia are the primary immune cells of the central nervous system and play a dual role in Parkinson’s disease, contributing to both protective clearance of pathological proteins and harmful neuroinflammation. In healthy tissue, microglia survey the environment, engulfing debris and misfolded proteins such as α-synuclein via phagocytosis and autophagy. In Parkinson’s disease, accumulations of misfolded α-synuclein trigger sustained microglial activation, shifting these cells towards pro-inflammatory states that release cytokines, reactive oxygen species and glutamate, ultimately exacerbating dopaminergic neuron loss in the substantia nigra. Emerging research highlights a spectrum of microglial phenotypes, from homeostatic to neurotoxic, governed by signalling pathways including Toll-like receptors and NF-κB. Understanding the molecular switches that dictate microglial responses offers avenues for therapeutic intervention aimed at restoring beneficial clearance functions while dampening chronic inflammation.

Research from Nature Portfolio

Recent studies have delineated a neuroprotective mechanism whereby microglia clear neuron-released α-synuclein through a selective autophagy pathway termed ‘synucleinphagy.’ Engagement of microglial Toll-like receptor 4 initiates NF-κB activation and upregulation of the autophagy receptor p62, enabling efficient engulfment and degradation of α-synuclein aggregates. Disruption of this pathway in animal models leads to accumulation of misfolded protein and accelerated degeneration of midbrain dopaminergic neurons, underscoring the importance of microglial autophagy in disease modulation. Complementary work in acute toxin-based models shows that genetic ablation of Toll-like receptor 4 attenuates microglial activation, reduces pro-inflammatory cytokine release and protects against neuronal loss, revealing this receptor as a key mediator of neuroinflammatory damage in Parkinson’s disease.

Microglial Activation in Parkinson's Disease publication trend

The graph below shows the total number of articles in microglial activation in parkinson's disease across all publications each year (not limited to Nature Index journals).

Technical terms

Microglia: Resident immune cells of the brain and spinal cord responsible for surveillance, phagocytosis and modulation of neuroinflammation.

α-Synuclein: A neuronal protein prone to misfolding and aggregation in Parkinson’s disease, forming toxic oligomers and fibrils.

Phagocytosis: Cellular process by which microglia engulf and internalise debris, pathogens or aggregated proteins for degradation.

Autophagy: Intracellular degradation pathway involving sequestration of cargo in autophagosomes and fusion with lysosomes.

Toll-like receptor (TLR): Pattern recognition receptor on microglia that detects molecular signatures of pathogens or misfolded proteins, initiating inflammatory signalling.

NF-κB pathway: A transcriptional regulator activated by stress or receptor signalling that controls expression of cytokines and autophagy-related genes.

References

1. Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration. Nature Communications (2020).
2. Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Scientific Reports (2013).
3. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes. Translational Neurodegeneration (2024).
4. Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype. Journal of Neuroinflammation (2024).
5. MerTK is a mediator of alpha-synuclein fibril uptake by human microglia. Brain (2023).